Related references
Note: Only part of the references are listed.Selection of Potential Therapeutic Bacteriophages that Lyse a CTX-M-15 Extended Spectrum β-Lactamase Producing Salmonella enterica Serovar Typhi Strain from the Democratic Republic of the Congo
Elene Kakabadze et al.
VIRUSES-BASEL (2018)
Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report
Serge Jennes et al.
CRITICAL CARE (2017)
Phage Therapy in the Era of Synthetic Biology
E. Magda Barbu et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Characterization of Newly Isolated Lytic Bacteriophages Active against Acinetobacter baumannii
Maia Merabishvili et al.
PLOS ONE (2014)
A Window of Opportunity to Control the Bacterial Pathogen Pseudomonas aeruginosa Combining Antibiotics and Phages
Clara Torres-Barcelo et al.
PLOS ONE (2014)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Synergistic Action of Gentamicin and Bacteriophage in a Continuous Culture Population of Staphylococcus aureus
Amy E. Kirby
PLOS ONE (2012)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials
Maya Merabishvili et al.
PLOS ONE (2009)
Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE
Louis B. Rice
JOURNAL OF INFECTIOUS DISEASES (2008)
Old dogma, new tricks - 21st century phage therapy
K Thiel
NATURE BIOTECHNOLOGY (2004)